Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02838394 · ClinicalTrials.gov registry record · NA

Dry Needling and Functional Improvement

A NA study, sponsored by Brigham Young University.

Terminated
Registry status
NA
Development phase
20
Enrollment target

NCT02838394: Clinical Trial NA study, sponsored by Brigham Young University.

NCT02838394 is a NA study that was terminated before completion, run by Brigham Young University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02838394, a NA study, was terminated before completion, sponsored by Brigham Young University.

TERMINATED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Dry Needling (DN) is a skilled intervention that uses acupuncture filiform needles that are inserted into myofascial trigger points or other tissues underneath the skin. It is used to treat myofascial or neuromusculoskeletal pain and to improve movement impairments. Although more and more physical therapists add this treatment tool to their skill box, there is uncertainty about its working mechanism and its efficacy. The latter is partially due to the challenging task of finding and using a true control or sham treatment. The investigators will use blunted needles, which will not perforate the skin, as sham treatment. This study will assess if DN of a trigger point in the gluteal muscles increases pain pressure threshold in that muscle, in another muscle innervated by the same segment (L4/5) and in an area not supplied by the same segment (i.e. the ipsilateral posterior shoulder). In addition, this study will assess if functionality, as measured by the Oswestry Disability Index (ODI) and 15-point Global Rating of Change Scale (GRoC) questionnaires, improves after 2-3 treatments (1 week) of DN.

Primary Outcome

Pain pressure threshold values as measured with algometer

Interventions

  • PROCEDURE Dry needling
  • OTHER Sham dry needling

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-12
Est. Completion 2023-08
Phase NA
Brigham Young University

10 total trials

Why NCT02838394 stopped before completion

NCT02838394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Dry needling is the first listed.

NCT02838394 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02838394 about?

NCT02838394 is a clinical study titled "Dry Needling and Functional Improvement". Dry Needling (DN) is a skilled intervention that uses acupuncture filiform needles that are inserted into myofascial trigger points or other tissues underneath the skin. It is used to treat myofascial or neuromusculoskeletal pain and to improve movement impairments. Although more and more physical t...

What is the current status of trial NCT02838394?

This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2016-12. Estimated completion is 2023-08.

What interventions are being tested in trial NCT02838394?

The interventions under investigation include: Dry needling (PROCEDURE), Sham dry needling (OTHER).

Who is sponsoring clinical trial NCT02838394?

This trial is sponsored by Brigham Young University, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02838394's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02838394, the US trial registry maintained by the National Library of Medicine. NCT02838394 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.